Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Obesity Science & Innovation Europe (OSI EU)
6 November 2026
nhow Amsterdam RAIAmsterdam
Book Now
Menu
Book
Key Sessions
Ekaterina Grinko
Keynote Presentation: Decoding The Future of Obesity Care: The Signals Worth Paying Attention To
Novo Nordisk
Annagret Van Der Aaa
Keynote Panel: From Lab to Launch - Navigating the European Obesity Therapeutics Landscape
Cantoni Therapeutics
keyboard_arrow_right

Obesity Science & Innovation EU - UTC +1

keyboard_arrow_leftSearch & Filter
search
Obesity Science & Innovation EU - UTC +1
search
08:00 - 08:30
Registration
Showing 1 of 1 Streams
08:30 - 08:40
Obesity Science & Innovation Europe Welcome
  • Kaitlin Dailey - Senior Conference Producer, Informa Connect
08:40 - 09:10
Keynote Presentation: Decoding The Future of Obesity Care: The Signals Worth Paying Attention To
  • Ekaterina Grinko - Business Innovation & Partnerships Lead Obesity & GLP-1, Novo Nordisk
09:10 - 10:00
Keynote Panel: From Lab to Launch - Navigating the European Obesity Therapeutics Landscape
  • Annagret Van Der Aaa - CEO, Cantoni Therapeutics
  • Ekaterina Grinko - Business Innovation & Partnerships Lead Obesity & GLP-1, Novo Nordisk
  • Steffen-Sebastian Bolz - CSO, Aphaia Pharma
  • Saleha Patel - Head of Pipeline and Commercialization Strategy, Constructive Bio
10:00 - 10:30
Morning Break
Showing 1 of 1 Streams
10:30 - 10:55
Presentation: Exploring A Selective Amylin Receptor Agonist for Metabolic Disease
  • Gabe Smolarz - VP Medical Affairs, Zealand Pharma
10:55 - 11:20
Presentation: The Promise Of Signal-biased Dual GLP-1/GIP Agonist Enicepatide in Weight Management
  • F. Hoffmann-La Roche - ., Hoffmann-La Roche
11:20 - 11:35
Spotlight Presentation Available

For more information please contact Roshni Shah– Roshni.shah@informa.com

11:35 - 12:00
Presentation: Genetically-Validated INHBE Silencing with SLN098 siRNA for Enhanced Fat Loss and Lean Mass Preservation
  • Lucas Bethge - VP, Group Leader Chemistry, Silence Therapeutics
12:00 - 12:25
Presentation: Energy Expenditure Modulation as an Emerging Therapeutic Strategy for Obesity
  • Martin Hey-Mogensen - Scientific Director, Emerging Obesity Mechanism, The Energy Expenditure Group, Novo Nordisk
12:25 - 13:30
Lunch Break
Showing 1 of 1 Streams
13:30 - 13:45
Presentation: Engineering Advanced GLP-1 Peptides Through Targeted Site-Specific Modifications
  • Robert Salmon - Head of Bioprocess, Constructive Bio
13:45 - 14:00
Presentation: Investigating FKBPL as an Emerging Metabolic Target in Obesity
  • Stephanie Annett - Senior Lecturer, RCSI
14:00 - 14:15
Spotlight Presentation Available

For more information please contact Roshni Shah– Roshni.shah@informa.com

14:15 - 14:30
Presentation: Enteroendocrine Cell Activation via Beaded Oral Glucose: A Multi-Hormonal Approach to Metabolic Regulation
  • Steffen-Sebastian Bolz - CSO, Aphaia Pharma
14:30 - 14:45
Presentation: Translational Medicine at the Crossroads of Obesity and Type 2 Diabetes: From Disease Mechanisms to Precision Therapeutics
  • Farhad Rezaee - Principle Investigator/ Project Leader, Erasmus Medical Center Rotterdam
14:45 - 15:00
Presentation: First-in-Class Small Molecule Targeting Adipocyte Futile Cycling for Weight Loss
  • Joanne Hsieh - Head of Metabolism, Gordian Biotechnology
15:00 - 15:30
Afternoon Break
Showing 1 of 1 Streams
15:30 - 15:55
Keynote Presentation: Integrating Digital Health Solutions With Obesity Therapeutics
15:55 - 16:20
Keynote Presentation: The Patient Perspective In Obesity Therapeutics
16:20 - 16:25
Close of OSI Europe 2026
Filter
Streams
Formats
Choose Day